1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor analysis
5.1 Value chain analysis
5.2 Porters Five Forces analysis
5.3 Demand & Supply: Gap analysis
5.4 Pricing analysis
5.5 Investment Opportunity analysis
5.6 Merger and Acquisition landscape
5.7 Upcoming trends
6. Global Neurosyphilis Market by Type
6.1 Asymptomatic neurosyphilis
6.2 Meningeal neurosyphilis
6.3 Meningovascular neurosyphilis
6.4 General paresis
6.5 Tabes dorsalis
6.6 Others
7. Global Neurosyphilis Market by Diagnosis
7.1 Physical exam
7.2 Blood test
7.2.1 Venereal disease research laboratory (VDRL) test
7.2.1 Fluorescent treponemal antibody absorption (FTA-ABS)
7.2.3 Rapid plasma reagin (RPR)
7.2.4 Treponema pallidum particle agglutination assay (TPPA)
7.3 Spinal tap
7.4 Imaging tests
7.4.1 Computed Tomography (CT)
7.4.2 X-rays
7.4.3 Magnetic resonance imaging (MRI)
7.5 Others
8. Global Neurosyphilis Market by Treatment
8.1 Antibiotic penicillin
8.1.1 Injection
8.1.2 Oral
8.2 Antibiotics probenecid
8.3 Ceftriaxone
8.4 Others
9. Global Neurosyphilis Market by End User
9.1 Hospital and clinics
9.2 Medical research centers
9.3 Academic institutes
9.4 Others
10. Global Neurosyphilis Market by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 The US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of Asia
10.5 Pacific
10.6 Middle East and Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Egypt
10.6.4 Rest of Middle East and Africa
11. Competitive Landscape
12. Company Profile
13. Conclusion
13.1 Key findings
13.1.1 From CEO’s viewpoint
13.1.2 Unmet needs of the market
13.2 Key companies to watch
13.3 Prediction of Neurosyphilis Market
14. Appendix